Key result
Combining radiofrequency ablation with liposomal doxorubicin significantly increased the peripheral band of cleaved caspase-3 positive cells to 77.7% compared to 57.0% with radiofrequency ablation alone.
Why the study?
Does combining radiofrequency ablation with liposomal doxorubicin increase tumor destruction via oxidative/nitrative stress and apoptosis in a rat mammary adenocarcinoma model?
Does combining radiofrequency ablation with liposomal doxorubicin increase tumor destruction via oxidative/nitrative stress and apoptosis in a rat mammary adenocarcinoma model?
Absolute Event Rate: 77.7% vs 57%
p-value: p=<0.03
Combining radiofrequency ablation with liposomal doxorubicin synergistically increases tumor destruction through enhanced cellular oxidative and nitrative stress and accelerated apoptosis.
Findings in rat model do not inform clinical practice; leaves open translation of combined RFA and liposomal doxorubicin to human tumors.
PURPOSE: To determine if oxidative and nitrative stress and/or apoptosis contribute to increased coagulation when combining radiofrequency (RF) ablation with liposomal doxorubicin. MATERIALS AND METHODS: Animal care committee approval was obtained. R3230 mammary adenocarcinomas in Fischer rats were treated with either RF ablation (n = 43), 1 mg of intravenously injected liposomal doxorubicin (n = 26), or combined therapy (n = 30) and were compared with control subjects (n = 11). A subset of animals receiving combination therapy (n = 24) were treated in the presence or absence of N-acetylcysteine (NAC) administered 24 hours and 1 hour before RF ablation. Tumors were analyzed 2 minutes to 72 hours after treatment to determine the temporal range of response by using immunohistochemical staining of the apoptosis marker cleaved caspase-3, phosphorylated gammaH2AX, and HSP70 and of markers of oxidative and nitrative stress (8-hydroxydeoxyguanosine [8-OHdG], 4-hydroxynonenal [4-HNE]-modified proteins, and nitrotyrosine [NT]). Statistical analyses, including t tests and analysis of variance for comparisons where appropriate, were performed. RESULTS: By 4 hours after RF ablation alone, a 0.48-mm +/- 0.13 (standard deviation) peripheral band with 57.0% +/- 7.3 cleaved caspase-3 positive cells was noted at the ablation margin, whereas a 0.73-mm +/- 0.18 band with 77.7% +/- 6.3 positivity was seen for combination therapy (P < .03 for both comparisons). Combination therapy caused increased and earlier staining for 4-HNE-modified proteins, 8-OHdG, NT, and gammaH2AX with colocalization to cleaved caspase-3 staining. A rim of increased HSP70 was identified peripheral to the area of cleaved caspase-3. Parameters of oxidative and nitrative stress were significantly inhibited by NAC 1 hour following RF ablation, resulting in decreased cleaved caspase-3 positivity (0.28-mm +/- 0.09 band of 25.9% +/- 7.4 positivity vs 0.59-mm +/- 0.11 band of 62.9% +/- 6.0 positivity, P < .001 for both comparisons). CONCLUSION: Combining RF ablation with liposomal doxorubicin increases cell injury and apoptosis in the zone of increased coagulation by using a mechanism that involves oxidative and nitrative stress that leads to accelerated apoptosis.
No takes yet. Share an insight, caveat, or question.
Solazzo et al. (2010) studied R3230 mammary adenocarcinomas (n=110). Radiofrequency ablation combined with liposomal doxorubicin vs. Radiofrequency ablation alone was evaluated on Cleaved caspase-3 positive cells at the ablation margin at 4 hours (p=<0.03). Combining radiofrequency ablation with liposomal doxorubicin significantly increased the peripheral band of cleaved caspase-3 positive cells to 77.7% compared to 57.0% with radiofrequency ablation alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: